124 related articles for article (PubMed ID: 12704670)
21. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
Wiest JS; Franklin WA; Drabkin H; Gemmill R; Sidransky D; Anderson MW
J Cell Biochem Suppl; 1997; 28-29():64-73. PubMed ID: 9589350
[TBL] [Abstract][Full Text] [Related]
22. Molecular serological diagnosis in transitional cell bladder cancer.
von Knobloch R; Brandt H; Hofmann R
Ann N Y Acad Sci; 2004 Jun; 1022():70-5. PubMed ID: 15251942
[TBL] [Abstract][Full Text] [Related]
23. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
[TBL] [Abstract][Full Text] [Related]
24. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R
J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059
[TBL] [Abstract][Full Text] [Related]
25. Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer.
Zhou X; Kemp BL; Khuri FR; Liu D; Lee JJ; Wu W; Hong WK; Mao L
Clin Cancer Res; 2000 Feb; 6(2):559-65. PubMed ID: 10690539
[TBL] [Abstract][Full Text] [Related]
26. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types.
Virmani AK; Fong KM; Kodagoda D; McIntire D; Hung J; Tonk V; Minna JD; Gazdar AF
Genes Chromosomes Cancer; 1998 Apr; 21(4):308-19. PubMed ID: 9559342
[TBL] [Abstract][Full Text] [Related]
27. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
[TBL] [Abstract][Full Text] [Related]
28. Molecular changes in the bronchial epithelium of patients with small cell lung cancer.
Wistuba II; Berry J; Behrens C; Maitra A; Shivapurkar N; Milchgrub S; Mackay B; Minna JD; Gazdar AF
Clin Cancer Res; 2000 Jul; 6(7):2604-10. PubMed ID: 10914700
[TBL] [Abstract][Full Text] [Related]
29. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
[TBL] [Abstract][Full Text] [Related]
30. 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer.
Carpagnano GE; Foschino-Barbaro MP; Mulé G; Resta O; Tommasi S; Mangia A; Carpagnano F; Stea G; Susca A; Di Gioia G; De Lena M; Paradiso A
Am J Respir Crit Care Med; 2005 Sep; 172(6):738-44. PubMed ID: 15947287
[TBL] [Abstract][Full Text] [Related]
31. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.
Carpagnano GE; Foschino-Barbaro MP; Spanevello A; Resta O; Carpagnano F; Mulé G; Pinto R; Tommasi S; Paradiso A
Am J Respir Crit Care Med; 2008 Feb; 177(3):337-41. PubMed ID: 17962633
[TBL] [Abstract][Full Text] [Related]
32. Fractional allele loss is a valuable marker for human lung cancer detection in sputum.
Arvanitis DA; Papadakis E; Zafiropoulos A; Spandidos DA
Lung Cancer; 2003 Apr; 40(1):55-66. PubMed ID: 12660007
[TBL] [Abstract][Full Text] [Related]
33. Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: follow-up study and prognostic significance.
Gonzalez R; Silva JM; Sanchez A; Dominguez G; Garcia JM; Chen XQ; Stroun M; Provencio M; España P; Anker P; Bonilla F
Ann Oncol; 2000 Sep; 11(9):1097-104. PubMed ID: 11061602
[TBL] [Abstract][Full Text] [Related]
34. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
[TBL] [Abstract][Full Text] [Related]
35. Clonal selection of adenocarcinoma of the lung as determined by loss of heterozygosity.
Dacic S; Finkelstein SD; Yousem SA
Exp Mol Pathol; 2005 Apr; 78(2):135-9. PubMed ID: 15713439
[TBL] [Abstract][Full Text] [Related]
36. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung.
Petersen I; Bujard M; Petersen S; Wolf G; Goeze A; Schwendel A; Langreck H; Gellert K; Reichel M; Just K; du Manoir S; Cremer T; Dietel M; Ried T
Cancer Res; 1997 Jun; 57(12):2331-5. PubMed ID: 9192802
[TBL] [Abstract][Full Text] [Related]
37. Molecular serological detection of DNA alterations in transitional cell carcinoma is highly sensitive and stage independent.
von Knobloch R; Brandt H; Schrader AJ; Heidenreich A; Hofmann R
Clin Cancer Res; 2004 Feb; 10(3):988-93. PubMed ID: 14871977
[TBL] [Abstract][Full Text] [Related]
38. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.
Grepmeier U; Dietmaier W; Merk J; Wild PJ; Obermann EC; Pfeifer M; Hofstaedter F; Hartmann A; Woenckhaus M
Int J Oncol; 2005 Aug; 27(2):481-8. PubMed ID: 16010431
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients.
Carpagnano GE; Spanevello A; Carpagnano F; Palladino GP; Prato R; Martinelli D; Digioia G; Foschino-Barbaro MP
Lung Cancer; 2009 Jun; 64(3):334-40. PubMed ID: 18995925
[TBL] [Abstract][Full Text] [Related]
40. Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinal tract cancer.
Hu N; Roth MJ; Emmert-Buck MR; Tang ZZ; Polymeropolous M; Wang QH; Goldstein AM; Han XY; Dawsey SM; Ding T; Giffen C; Taylor PR
Clin Cancer Res; 1999 Nov; 5(11):3476-82. PubMed ID: 10589761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
